Obesity-related hypogonadism: a reversible condition
- PMID: 28645905
- PMCID: PMC5535048
- DOI: 10.1136/bcr-2017-220416
Obesity-related hypogonadism: a reversible condition
Abstract
Obesity is associated with hypogonadism. While this association is widely accepted, the underlying mechanisms remain unclear. Furthermore, obesity is a risk factor for hypogonadism and conversely hypogonadism may be a risk factor for obesity. We present the case of a morbidly obese man aged 30 years with hypogonadotrophic hypogonadism that underwent a Roux-en-Y gastric bypass operation. Following the surgical treatment of his obesity, the testosterone level returned to normal with improvements in hypogonadal symptoms, which allowed discontinuation of exogenous testosterone therapy. This case report demonstrates reversal of hypogonadism following weight loss with restoration of gonadal function.
Keywords: Endocrine system; Gastrointestinal surgery; Metabolic disorders; Obesity (nutrition); Pituitary disorders.
© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Effects of Bariatric Surgery in Male Obesity-Associated Hypogonadism.Obes Surg. 2019 Jul;29(7):2115-2125. doi: 10.1007/s11695-019-03829-0. Obes Surg. 2019. PMID: 31065918
-
Hypogonadism as an additional indication for bariatric surgery in male morbid obesity?Eur J Endocrinol. 2014 Nov;171(5):555-60. doi: 10.1530/EJE-14-0596. Epub 2014 Aug 12. Eur J Endocrinol. 2014. PMID: 25117463
-
Gonadal status and outcome of bariatric surgery in obese men.Clin Endocrinol (Oxf). 2014 Sep;81(3):378-86. doi: 10.1111/cen.12366. Epub 2013 Dec 12. Clin Endocrinol (Oxf). 2014. PMID: 24237302
-
A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.J Clin Endocrinol Metab. 2017 Mar 1;102(3):1067-1075. doi: 10.1210/jc.2016-3580. J Clin Endocrinol Metab. 2017. PMID: 28359097 Free PMC article. Review.
-
MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.Eur J Endocrinol. 2020 Dec;183(6):R167-R183. doi: 10.1530/EJE-20-0394. Eur J Endocrinol. 2020. PMID: 33105105 Review.
Cited by
-
Obesity and Hypogonadism-A Narrative Review Highlighting the Need for High-Quality Data in Adolescents.Children (Basel). 2019 May 1;6(5):63. doi: 10.3390/children6050063. Children (Basel). 2019. PMID: 31052376 Free PMC article. Review.
-
Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial.Eur J Nutr. 2019 Mar;58(2):673-680. doi: 10.1007/s00394-018-1666-5. Epub 2018 Mar 15. Eur J Nutr. 2019. PMID: 29546692 Clinical Trial.
References
-
- Dixon J, Roberts C. Welsh Health Survey 2015: health-related lifestyle. Wales, UK: Health Statistics and Analysis Unit, Welsh Government, 2016.
-
- Fuller E, Mindell J, Prior G. Health Survey for England 2015. London: NHS Digital, 2016.
-
- McPherson K, Marsh T, Brown M. Foresight tackling obesities: future choices – modelling future trends in obesity and the impact on health. 2007. Future Choices http://www.foresight.gov.uk
-
- National institute for health and care excellence. clinical assessment and management (2016) National Institute for Health and Care Excellence Quality standard 127 Obesity, 2016.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials